DAVID J MORGANS JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID J MORGANS JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID J MORGANS JR. DAVID J MORGANS JR is EVP-Preclinical R&D in CYTOKINETICS INC ($CYTK) and SVP-Drug Discovery and Dev in CYTOKINETICS INC ($CYTK) and SVP-Preclinical R&D in CYTOKINETICS INC ($CYTK).
Latest Insider Trading Transactions of DAVID J MORGANS JR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2011 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 1.57 | 123,957 | 194,612 | 123,957 | |
Mar 01 2011 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 1.57 | 51,043 | 80,138 | 51,043 | |
Feb 26 2010 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 3.08 | 97,558 | 300,479 | 97,558 | |
Feb 26 2010 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 3.08 | 37,442 | 115,321 | 37,442 | |
Oct 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.24 | 200 | 1,048 | 42,000 | 42.2 K to 42 K (-0.47 %) |
Oct 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.23 | 200 | 1,046 | 42,200 | 42.4 K to 42.2 K (-0.47 %) |
Oct 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.22 | 1,400 | 7,308 | 42,400 | 43.8 K to 42.4 K (-3.20 %) |
Oct 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.20 | 534 | 2,777 | 43,800 | 44.3 K to 43.8 K (-1.20 %) |
Oct 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.19 | 4,400 | 22,836 | 44,334 | 48.7 K to 44.3 K (-9.03 %) |
Oct 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.17 | 766 | 3,960 | 48,734 | 49.5 K to 48.7 K (-1.55 %) |
Sep 29 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.50 | 2,500 | 13,750 | 49,500 | 52 K to 49.5 K (-4.81 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 5.00 | 2,500 | 12,500 | 52,000 | 54.5 K to 52 K (-4.59 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.78 | 100 | 478 | 54,500 | 54.6 K to 54.5 K (-0.18 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.77 | 400 | 1,908 | 54,600 | 55 K to 54.6 K (-0.73 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.77 | 100 | 477 | 55,000 | 55.1 K to 55 K (-0.18 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.76 | 300 | 1,429 | 55,100 | 55.4 K to 55.1 K (-0.54 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.76 | 1,200 | 5,712 | 55,400 | 56.6 K to 55.4 K (-2.12 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.75 | 500 | 2,375 | 56,600 | 57.1 K to 56.6 K (-0.88 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.75 | 400 | 1,900 | 57,100 | 57.5 K to 57.1 K (-0.70 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.74 | 300 | 1,422 | 57,500 | 57.8 K to 57.5 K (-0.52 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.73 | 1,400 | 6,622 | 57,800 | 59.2 K to 57.8 K (-2.36 %) |
Sep 22 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 4.69 | 300 | 1,407 | 59,200 | 59.5 K to 59.2 K (-0.50 %) |
Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.61 | 100 | 161 | 59,500 | 59.6 K to 59.5 K (-0.17 %) |
Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.58 | 100 | 158 | 59,600 | 59.7 K to 59.6 K (-0.17 %) |
Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.55 | 900 | 1,395 | 59,700 | 60.6 K to 59.7 K (-1.49 %) |
Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.54 | 3,700 | 5,698 | 60,600 | 64.3 K to 60.6 K (-5.75 %) |
Mar 03 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 1.52 | 200 | 304 | 64,300 | 64.5 K to 64.3 K (-0.31 %) |
Mar 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 1.85 | 106,249 | 196,561 | 106,249 | |
Mar 02 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 1.85 | 43,751 | 80,939 | 43,751 | |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.19 | 500 | 1,095 | 64,500 | 65 K to 64.5 K (-0.77 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.17 | 950 | 2,062 | 65,000 | 66 K to 65 K (-1.44 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.16 | 300 | 649 | 65,950 | 66.3 K to 66 K (-0.45 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.16 | 1,050 | 2,268 | 66,250 | 67.3 K to 66.3 K (-1.56 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.15 | 300 | 646 | 67,300 | 67.6 K to 67.3 K (-0.44 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.15 | 500 | 1,075 | 67,600 | 68.1 K to 67.6 K (-0.73 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.13 | 500 | 1,065 | 68,100 | 68.6 K to 68.1 K (-0.73 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.11 | 400 | 844 | 68,600 | 69 K to 68.6 K (-0.58 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.11 | 400 | 843 | 69,000 | 69.4 K to 69 K (-0.58 %) |
Feb 04 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.07 | 100 | 207 | 69,400 | 69.5 K to 69.4 K (-0.14 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.89 | 1,125 | 3,251 | 69,500 | 70.6 K to 69.5 K (-1.59 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.88 | 847 | 2,439 | 70,625 | 71.5 K to 70.6 K (-1.19 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.87 | 900 | 2,583 | 71,472 | 72.4 K to 71.5 K (-1.24 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.85 | 400 | 1,140 | 72,372 | 72.8 K to 72.4 K (-0.55 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.81 | 200 | 562 | 72,772 | 73 K to 72.8 K (-0.27 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.80 | 300 | 840 | 72,972 | 73.3 K to 73 K (-0.41 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.79 | 128 | 357 | 73,272 | 73.4 K to 73.3 K (-0.17 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.78 | 100 | 278 | 73,400 | 73.5 K to 73.4 K (-0.14 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.76 | 288 | 795 | 73,500 | 73.8 K to 73.5 K (-0.39 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.75 | 312 | 858 | 73,788 | 74.1 K to 73.8 K (-0.42 %) |
Jan 05 2009 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.71 | 400 | 1,084 | 74,100 | 74.5 K to 74.1 K (-0.54 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.39 | 100 | 239 | 74,500 | 74.6 K to 74.5 K (-0.13 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.38 | 200 | 476 | 74,600 | 74.8 K to 74.6 K (-0.27 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.30 | 100 | 230 | 74,800 | 74.9 K to 74.8 K (-0.13 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.29 | 100 | 229 | 74,900 | 75 K to 74.9 K (-0.13 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.24 | 460 | 1,030 | 75,000 | 75.5 K to 75 K (-0.61 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.22 | 700 | 1,554 | 75,460 | 76.2 K to 75.5 K (-0.92 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.14 | 429 | 918 | 76,160 | 76.6 K to 76.2 K (-0.56 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.12 | 211 | 447 | 76,589 | 76.8 K to 76.6 K (-0.27 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.10 | 1,165 | 2,447 | 76,800 | 78 K to 76.8 K (-1.49 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.09 | 155 | 324 | 77,965 | 78.1 K to 78 K (-0.20 %) |
Dec 02 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.08 | 1,380 | 2,870 | 78,120 | 79.5 K to 78.1 K (-1.74 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.04 | 100 | 304 | 79,500 | 79.6 K to 79.5 K (-0.13 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.03 | 300 | 909 | 79,600 | 79.9 K to 79.6 K (-0.38 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.02 | 300 | 906 | 79,900 | 80.2 K to 79.9 K (-0.37 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 3.01 | 100 | 301 | 80,200 | 80.3 K to 80.2 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.99 | 100 | 299 | 80,300 | 80.4 K to 80.3 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.98 | 100 | 298 | 80,400 | 80.5 K to 80.4 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.97 | 100 | 297 | 80,500 | 80.6 K to 80.5 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.95 | 600 | 1,770 | 80,600 | 81.2 K to 80.6 K (-0.74 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.94 | 200 | 588 | 81,200 | 81.4 K to 81.2 K (-0.25 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.94 | 100 | 294 | 81,400 | 81.5 K to 81.4 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.93 | 100 | 293 | 81,500 | 81.6 K to 81.5 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.92 | 100 | 292 | 81,600 | 81.7 K to 81.6 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.90 | 200 | 581 | 81,700 | 81.9 K to 81.7 K (-0.24 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.90 | 87 | 252 | 81,900 | 82 K to 81.9 K (-0.11 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.89 | 1,500 | 4,335 | 81,987 | 83.5 K to 82 K (-1.80 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.87 | 13 | 37 | 83,487 | 83.5 K to 83.5 K (-0.02 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.86 | 100 | 286 | 83,500 | 83.6 K to 83.5 K (-0.12 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.85 | 300 | 855 | 83,600 | 83.9 K to 83.6 K (-0.36 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.84 | 500 | 1,420 | 83,900 | 84.4 K to 83.9 K (-0.59 %) |
Nov 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Sell | S | 2.83 | 100 | 283 | 84,400 | 84.5 K to 84.4 K (-0.12 %) |
Mar 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 3.37 | 122,286 | 412,104 | 122,286 | |
Mar 04 2008 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | EVP-Preclinical R&D | Option Exercise | A | 3.37 | 27,714 | 93,396 | 27,714 | |
Oct 01 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Sell | S | 5.09 | 5,000 | 25,450 | 84,500 | 89.5 K to 84.5 K (-5.59 %) |
Sep 14 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Option Exercise | M | 1.20 | 32,000 | 38,400 | 0 | |
Sep 14 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Sell | S | 4.75 | 5,000 | 23,750 | 89,500 | 94.5 K to 89.5 K (-5.29 %) |
Sep 14 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Buy | M | 1.20 | 32,000 | 38,400 | 94,500 | 62.5 K to 94.5 K (+51.20 %) |
Jul 02 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Sell | S | 6.00 | 5,000 | 30,000 | 62,500 | 67.5 K to 62.5 K (-7.41 %) |
Jun 19 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Option Exercise | M | 1.20 | 22,500 | 27,000 | 32,000 | |
Jun 19 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Option Exercise | M | 1.20 | 5,000 | 6,000 | 0 | |
Jun 19 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Sell | S | 6.46 | 5,000 | 32,300 | 67,500 | 72.5 K to 67.5 K (-6.90 %) |
Jun 19 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Buy | M | 1.20 | 22,500 | 27,000 | 72,500 | 50 K to 72.5 K (+45.00 %) |
Jun 19 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Preclinical R&D | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Mar 16 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | A | 6.81 | 50,190 | 341,794 | 50,190 | |
Mar 16 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | A | 6.81 | 14,810 | 100,856 | 14,810 | |
Jan 17 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 5,000 | |
Jan 17 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 8.31 | 5,000 | 41,550 | 45,000 | 50 K to 45 K (-10.00 %) |
Jan 17 2007 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Dec 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 10,000 | |
Dec 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 6.95 | 5,000 | 34,750 | 45,000 | 50 K to 45 K (-10.00 %) |
Dec 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Nov 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 15,000 | |
Nov 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.80 | 5,000 | 39,000 | 45,000 | 50 K to 45 K (-10.00 %) |
Nov 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Oct 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 20,000 | |
Oct 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 6.67 | 5,000 | 33,350 | 45,000 | 50 K to 45 K (-10.00 %) |
Oct 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Sep 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 25,000 | |
Sep 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.02 | 5,000 | 35,100 | 45,000 | 50 K to 45 K (-10.00 %) |
Sep 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Aug 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 30,000 | |
Aug 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 6.00 | 5,000 | 30,000 | 45,000 | 50 K to 45 K (-10.00 %) |
Aug 18 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Jul 26 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 3,490 | 4,188 | 35,000 | |
Jul 26 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 6.00 | 3,490 | 20,940 | 45,000 | 48.5 K to 45 K (-7.20 %) |
Jul 26 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 3,490 | 4,188 | 48,490 | 45 K to 48.5 K (+7.76 %) |
Jul 26 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 1,510 | 1,812 | 38,490 | |
Jul 26 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 6.00 | 1,510 | 9,060 | 45,000 | 46.5 K to 45 K (-3.25 %) |
Jul 26 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 1,510 | 1,812 | 46,510 | 45 K to 46.5 K (+3.36 %) |
Jun 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 40,000 | |
Jun 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 0.58 | 25,000 | 14,500 | 0 | |
Jun 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 6.93 | 5,000 | 34,650 | 45,000 | 50 K to 45 K (-10.00 %) |
Jun 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 50,000 | 45 K to 50 K (+11.11 %) |
Jun 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 0.58 | 25,000 | 14,500 | 45,000 | 20 K to 45 K (+125.00 %) |
May 17 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.20 | 5,000 | 6,000 | 45,000 | |
May 17 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.03 | 5,000 | 35,150 | 20,000 | 25 K to 20 K (-20.00 %) |
May 17 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.20 | 5,000 | 6,000 | 25,000 | 20 K to 25 K (+25.00 %) |
Apr 17 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.00 | 5,000 | 5,000 | 0 | |
Apr 17 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.34 | 5,000 | 36,700 | 20,000 | 25 K to 20 K (-20.00 %) |
Apr 17 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.00 | 5,000 | 5,000 | 25,000 | 20 K to 25 K (+25.00 %) |
Mar 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.00 | 5,000 | 5,000 | 5,000 | |
Mar 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.01 | 5,000 | 35,050 | 20,000 | 25 K to 20 K (-20.00 %) |
Mar 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.00 | 5,000 | 5,000 | 25,000 | 20 K to 25 K (+25.00 %) |
Mar 03 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | A | 7.15 | 44,612 | 318,976 | 44,612 | |
Mar 03 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | A | 7.15 | 15,388 | 110,024 | 15,388 | |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.00 | 4,300 | 4,300 | 10,000 | |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.00 | 300 | 300 | 14,300 | |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.00 | 100 | 100 | 14,600 | |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 1.00 | 300 | 300 | 14,700 | |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.18 | 4,300 | 30,874 | 20,000 | 24.3 K to 20 K (-17.70 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.00 | 4,300 | 4,300 | 24,300 | 20 K to 24.3 K (+21.50 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.19 | 300 | 2,157 | 20,000 | 20.3 K to 20 K (-1.48 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.00 | 300 | 300 | 20,300 | 20 K to 20.3 K (+1.50 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.20 | 100 | 720 | 20,000 | 20.1 K to 20 K (-0.50 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.00 | 100 | 100 | 20,100 | 20 K to 20.1 K (+0.50 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 7.23 | 300 | 2,169 | 20,000 | 20.3 K to 20 K (-1.48 %) |
Feb 16 2006 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 1.00 | 300 | 300 | 20,300 | 20 K to 20.3 K (+1.50 %) |
Nov 14 2005 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Option Exercise | M | 0.58 | 20,000 | 11,600 | 25,000 | |
Nov 14 2005 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Buy | M | 0.58 | 20,000 | 11,600 | 20,000 | 0 to 20 K |
Nov 04 2005 | CYTK | CYTOKINETICS INC | MORGANS DAVID J JR | SVP-Drug Discovery ... | Sell | S | 8.00 | 5,000 | 40,000 | 0 | 5 K to 0 (-100.00 %) |